MedPath
HSA Approval

APO-SUCRALFATE TABLET 1 g

SIN08585P

APO-SUCRALFATE TABLET 1 g

APO-SUCRALFATE TABLET 1 g

February 27, 1996

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A02BX02

sucralfate

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

SUCRALFATE

1 g

Sucralfate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-SUCRALFATE TABLET 1 g - HSA Approval | MedPath